Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 38991177.
- Also identified by DOI 10.1200/PO.24.00006 and PMC identifier 11285011.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Benefits and limitations in using NCCN guidelines to distinguish TP53 CH from mosaic LFS.
Medical subject headings
- Mosaicism
- Tumor Suppressor Protein p53